Healthcare provider profile · identity verified

Darrell Blake Leslie, M.D.

Family Practice · PADUCAH, KY · NPI 1588741755

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	620	150
Lisinopril	Lisinopril	558	142
Amlodipine Besylate	Amlodipine Besylate	483	112
Levothyroxine Sodium	Levothyroxine Sodium	406	96
Omeprazole	Omeprazole	342	85
Metformin Hcl	Metformin Hcl	321	77
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	319	58
Losartan Potassium	Losartan Potassium	312	73
Rosuvastatin Calcium	Rosuvastatin Calcium	292	71
Hydrochlorothiazide	Hydrochlorothiazide	271	72
Pravastatin Sodium	Pravastatin Sodium	246	63
Tamsulosin Hcl	Tamsulosin Hcl	242	59
Metoprolol Succinate	Metoprolol Succinate	218	56
Pantoprazole Sodium	Pantoprazole Sodium	212	61
Simvastatin	Simvastatin	198	47
Trazodone Hcl	Trazodone Hcl	190	49
Carvedilol	Carvedilol	185	37
Tizanidine Hcl	Tizanidine Hcl	183	45
Montelukast Sodium	Montelukast Sodium	172	38
Gabapentin	Gabapentin	146	49
Sertraline Hcl	Sertraline Hcl	146	41
Furosemide	Furosemide	142	45
Meloxicam	Meloxicam	138	32
Duloxetine Hcl	Duloxetine Hcl	135	25
Allopurinol	Allopurinol	132	30
Alprazolam	Alprazolam	128	21
Albuterol Sulfate Hfa	Albuterol Sulfate	127	48
Ozempic	Semaglutide	125	24
Metoprolol Tartrate	Metoprolol Tartrate	122	32
Eliquis	Apixaban	119	16
Temazepam	Temazepam	116	17
Fluticasone Propionate	Fluticasone Propionate	108	38
Famotidine	Famotidine	96	22
Escitalopram Oxalate	Escitalopram Oxalate	94	21
Jardiance	Empagliflozin	94	22
Zolpidem Tartrate	Zolpidem Tartrate	91	17
Irbesartan	Irbesartan	89	21
Celecoxib	Celecoxib	87	27
Lorazepam	Lorazepam	86	20
Mounjaro	Tirzepatide	86	17
Ropinirole Hcl	Ropinirole Hcl	80	18
Buspirone Hcl	Buspirone Hcl	79	21
Fluoxetine Hcl	Fluoxetine Hcl	79	19
Prednisone	Prednisone	74	51
Synthroid	Levothyroxine Sodium	73	17
Metformin Hcl Er	Metformin Hcl	71	16
Alendronate Sodium	Alendronate Sodium	68	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	16
Valsartan	Valsartan	67	11
Pregabalin	Pregabalin	65	17
Esomeprazole Magnesium	Esomeprazole Magnesium	64	22
Ezetimibe	Ezetimibe	63	17
Clopidogrel	Clopidogrel Bisulfate	62	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	17
Januvia	Sitagliptin Phosphate	62	14
Potassium Chloride	Potassium Chloride	62	23
Bupropion Xl	Bupropion Hcl	61	12
Diazepam	Diazepam	59	16
Tresiba Flextouch U-100	Insulin Degludec	59	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	57	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	13
Diclofenac Sodium	Diclofenac Sodium	54	15
Triamcinolone Acetonide	Triamcinolone Acetonide	52	19
Cefdinir	Cefdinir	51	38
Bumetanide	Bumetanide	49	13
Dicyclomine Hcl	Dicyclomine Hcl	48	12
Glipizide Er	Glipizide	48	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	48	12
Clonidine Hcl	Clonidine Hcl	47	17
Fenofibrate	Fenofibrate	47	13
Citalopram Hbr	Citalopram Hydrobromide	46	15
Atenolol	Atenolol	45	suppressed
Azithromycin	Azithromycin	43	40
Clonazepam	Clonazepam	43	suppressed
Spironolactone	Spironolactone	42	12
Doxazosin Mesylate	Doxazosin Mesylate	40	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	40	suppressed
Tramadol Hcl	Tramadol Hcl	40	suppressed
Glipizide	Glipizide	39	11
Mirtazapine	Mirtazapine	38	suppressed
Estradiol	Estradiol	37	suppressed
Nystatin	Nystatin	37	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Ventolin Hfa	Albuterol Sulfate	36	11
Nabumetone	Nabumetone	34	suppressed
Ondansetron Hcl	Ondansetron Hcl	34	11
Finasteride	Finasteride	33	11
Methylprednisolone	Methylprednisolone	33	32
Nifedipine Er	Nifedipine	32	suppressed
Ondansetron Odt	Ondansetron	32	15
Ramipril	Ramipril	32	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Baclofen	Baclofen	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Xarelto	Rivaroxaban	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	13
Warfarin Sodium	Warfarin Sodium	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Eszopiclone	Eszopiclone	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Promethazine Hcl	Promethazine Hcl	24	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	22	suppressed
Linzess	Linaclotide	22	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	suppressed
Primidone	Primidone	20	suppressed
Testosterone	Testosterone	20	suppressed
Calcitriol	Calcitriol	19	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Fluconazole	Fluconazole	17	14
Novolog Flexpen	Insulin Aspart	17	suppressed
Vascepa	Icosapent Ethyl	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Glimepiride	Glimepiride	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Valacyclovir	Valacyclovir Hcl	16	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Amoxicillin	Amoxicillin	14	12
Aripiprazole	Aripiprazole	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Colesevelam Hcl	Colesevelam Hcl	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Niacin Er	Niacin	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Colestipol Hcl	Colestipol Hcl	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Prasugrel Hcl	Prasugrel Hcl	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error